These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31421028)

  • 1. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
    Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal Dexamethasone Implant in the Treatment of Diabetic Macular Edema Focusing on the Role of OCT Biomarkers.
    Mudroch T; Hrevuš M; Karhanová M; Řehák J; Marešová K
    Cesk Slov Oftalmol; 2024; 80(Ahead of print):1-8. PubMed ID: 38925895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
    Sun JK; Lin MM; Lammer J; Prager S; Sarangi R; Silva PS; Aiello LP
    JAMA Ophthalmol; 2014 Nov; 132(11):1309-16. PubMed ID: 25058813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of optical coherence tomography after switch to dexamethasone in diabetic macular edema.
    Cavalleri M; Cicinelli MV; Parravano M; Varano M; De Geronimo D; Sacconi R; Bandello F; Querques G
    Acta Diabetol; 2020 Feb; 57(2):163-171. PubMed ID: 31375899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
    Iglicki M; Busch C; Zur D; Okada M; Mariussi M; Chhablani JK; Cebeci Z; Fraser-Bell S; Chaikitmongkol V; Couturier A; Giancipoli E; Lupidi M; Rodríguez-Valdés PJ; Rehak M; Fung AT; Goldstein M; Loewenstein A
    Retina; 2019 Jan; 39(1):44-51. PubMed ID: 29697589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.
    Borrelli E; Parravano M; Querques L; Sacconi R; Giorno P; De Geronimo D; Bandello F; Querques G
    Acta Diabetol; 2020 May; 57(5):543-548. PubMed ID: 31749052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
    Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
    Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a dexamethasone implant to treat macular edema following pars plana vitrectomy and removal of the primary epiretinal membrane.
    Boz AAE; Çelik E; Atum M; Çakır B; Aksoy NÖ; Özmen S; Doğan E; Yuvacı İ
    Int Ophthalmol; 2024 Aug; 44(1):340. PubMed ID: 39102035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
    Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
    Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.
    Mimouni M; Segev O; Dori D; Geffen N; Flores V; Segal O
    Am J Ophthalmol; 2017 Oct; 182():160-167. PubMed ID: 28837790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.